Oscar Health (NYSE:OSCR) Shares Down 4.5% – What’s Next?

Oscar Health, Inc. (NYSE:OSCR)’s stock price traded down 4.5% during trading on Monday . The company traded as low as $13.16 and last traded at $13.46. 733,851 shares changed hands during trading, a decline of 79% from the average session volume of 3,486,025 shares. The stock had previously closed at $14.09.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. UBS Group started coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target for the company. Jefferies Financial Group assumed coverage on Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target on the stock. Finally, Piper Sandler reiterated an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Oscar Health has an average rating of “Hold” and an average target price of $21.56.

Oscar Health Stock Down 1.5 %

The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a market capitalization of $3.31 billion, a P/E ratio of -223.30 and a beta of 1.63. The company’s 50-day simple moving average is $15.73 and its two-hundred day simple moving average is $17.31.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter last year, the firm posted ($0.29) earnings per share. The company’s revenue was up 68.3% compared to the same quarter last year. As a group, research analysts expect that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Insider Buying and Selling

In other Oscar Health news, CAO Victoria Baltrus sold 8,078 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $146,050.24. Following the sale, the chief accounting officer now owns 146,036 shares in the company, valued at $2,640,330.88. The trade was a 5.24 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Vice Chairman Joshua Kushner acquired 276,040 shares of the company’s stock in a transaction on Monday, November 11th. The shares were bought at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the acquisition, the insider now directly owns 5,031,262 shares in the company, valued at approximately $68,324,537.96. The trade was a 5.80 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. 25.11% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Oscar Health

A number of hedge funds have recently made changes to their positions in OSCR. Raymond James & Associates purchased a new stake in shares of Oscar Health during the 2nd quarter worth approximately $3,168,000. Bank of New York Mellon Corp lifted its position in Oscar Health by 161.4% during the second quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company’s stock valued at $22,038,000 after purchasing an additional 860,226 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Oscar Health by 26.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,210 shares of the company’s stock worth $383,000 after buying an additional 5,138 shares in the last quarter. Panagora Asset Management Inc. increased its holdings in shares of Oscar Health by 15.1% in the 2nd quarter. Panagora Asset Management Inc. now owns 254,780 shares of the company’s stock worth $4,031,000 after buying an additional 33,508 shares during the last quarter. Finally, Principal Financial Group Inc. raised its position in shares of Oscar Health by 40.8% during the 2nd quarter. Principal Financial Group Inc. now owns 26,266 shares of the company’s stock valued at $416,000 after buying an additional 7,616 shares in the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.